Chengdu Kanghong Pharmaceuticals Group Co Ltd Cash Flow Quality Index
Chengdu Kanghong Pharmaceuticals Group Co Ltd cash flow quality index. Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Cash Flow Quality Index of 1.66x as of September 2025. Operating cash flow of CN¥504.02 Million exceeds net income of CN¥303.21 Million, indicating high earnings quality where cash backs reported profits. See Chengdu Kanghong Pharmaceuticals Group C leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
Cash flow quality index of Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2009 to 2025. Historical Cash Flow Quality Index for Chengdu Kanghong Pharmaceuticals Group Co Ltd across 16 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Chengdu Kanghong Pharmaceuticals Group C (002773) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Chengdu Kanghong Pharmaceuticals Group Co Ltd Cash Flow Quality Index by Year (2009–2025)
Chengdu Kanghong Pharmaceuticals Group Co Ltd cash flow quality index by year from 2009 to 2025. Year-by-year earnings quality comparison for Chengdu Kanghong Pharmaceuticals Group Co Ltd. For the full cash flow conversion analysis, see Chengdu Kanghong Pharmaceuticals Group C (002773) cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.29x | CN¥1.50 Billion | CN¥1.16 Billion | ▲ +7.8% |
| 2024 | 1.20x | CN¥1.41 Billion | CN¥1.18 Billion | ▲ +1.5% |
| 2023 | 1.18x | CN¥1.22 Billion | CN¥1.03 Billion | ▲ +10.6% |
| 2022 | 1.07x | CN¥925.15 Million | CN¥865.81 Million | ▼ -8.9% |
| 2021 | 1.17x | CN¥494.11 Million | CN¥421.08 Million | ▲ +3.8% |
| 2019 | 1.13x | CN¥812.15 Million | CN¥718.19 Million | ▲ +124.0% |
| 2018 | 0.50x | CN¥350.88 Million | CN¥694.94 Million | ▼ -57.6% |
| 2017 | 1.19x | CN¥766.86 Million | CN¥644.20 Million | ▼ -30.1% |
| 2016 | 1.70x | CN¥846.35 Million | CN¥496.75 Million | ▲ +39.2% |
| 2015 | 1.22x | CN¥481.97 Million | CN¥393.81 Million | ▲ +16.1% |
| 2014 | 1.05x | CN¥291.38 Million | CN¥276.47 Million | ▲ +0.9% |
| 2013 | 1.04x | CN¥333.31 Million | CN¥319.13 Million | ▼ -23.7% |
| 2012 | 1.37x | CN¥281.84 Million | CN¥205.78 Million | ▲ +36.0% |
| 2011 | 1.01x | CN¥168.86 Million | CN¥167.67 Million | ▼ -20.1% |
| 2010 | 1.26x | CN¥136.79 Million | CN¥108.51 Million | ▼ -4.1% |
| 2009 | 1.32x | CN¥108.42 Million | CN¥82.45 Million | — |